Modulation of Autophagy and Nitric Oxide Signaling Via Glycyrrhizic Acid and 7-Nitroindazole in MPTP-induced Parkinson's Disease Model

Overview

Journal Ann Neurosci

Publisher Sage Publications

Date 2025 Jan 22

PMID 39840143

Authors

Shipra Kartik

Rishi Pal

Manju J Chaudhary

Rajendra Nath

Madhu Kumar

Affiliations

Soon will be listed here.

Abstract

Background: Parkinson's disease (PD) is characterized by dopaminergic (DA) neuron loss, Lewy body build-up, and motor dysfunction. One of the primary pathogenic mechanisms of PD development is autophagy dysfunction and nitric oxide-mediated neurotoxicity.

Purpose: The current study focuses on autophagy and nitric oxide (NO) signaling roles in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-intoxicated PD mice and their protection by their modulators.

Method: BALB/c mice were administered MPTP (30 mg/kg/i.p/day) for five consecutive days in order to create a PD model. Following MPTP poisoning, the doses of GA (16.8 mg/kg/day/i.p.), 7-nitroindazole (7-NI) (10 mg/kg/day/i.p.), and their combination were administered once daily for 14 days. Animals were observed for behavioral and locomotor changes, biochemical examination, inflammatory mediators, and analysis of molecular markers.

Results: GA, 7-NI alone significantly reduced MPTP-induced locomotor, behavioral, and oxidative damage. Additionally, in MPTP-intoxicated animals, 7-NI and GA had protective effects on dopamine levels, TH positive DA neurons, inflammatory cytokines interleukin 1β (IL-1β), tumor necrosis factor-alpha (TNF-α), nuclear factor-kappa B (NF-κB), and cyclooxygenase-2 (Cox-2) concentration. Furthermore, GA increases LC3BII expression, which in turn increases autophagy. It also decreases total NO content, and a significant response of 7-NI demonstrates their interaction, which is neuroprotective.

Conclusion: Present research suggests that dysregulation of autophagy and NO-mediated neuroinflammation are involved in the pathogenesis and progression of MPTP-induced PD. The use of two pharmacotherapeutics, GA and 7-NI, respectively, significantly reduces MPTP-induced PD distortions and their interaction enhances the overall protective effect, suggesting that these pharmacological agents may be used for the treatment of PD.

References

Wirawan E, Vanden Berghe T, Lippens S, Agostinis P, Vandenabeele P . Autophagy: for better or for worse. Cell Res. 2011; 22(1):43-61. PMC: 3351915. DOI: 10.1038/cr.2011.152. View

Przedborski S, Jackson-Lewis V, Yokoyama R, Shibata T, Dawson V, Dawson T . Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity. Proc Natl Acad Sci U S A. 1996; 93(10):4565-71. PMC: 39317. DOI: 10.1073/pnas.93.10.4565. View

Pubill D, Chipana C, Camins A, Pallas M, Camarasa J, Escubedo E . Free radical production induced by methamphetamine in rat striatal synaptosomes. Toxicol Appl Pharmacol. 2005; 204(1):57-68. DOI: 10.1016/j.taap.2004.08.008. View

Jang A, Liew H, Kim Y, Choi H, Kim S, Lee S . p35 deficiency accelerates HMGB-1-mediated neuronal death in the early stages of an Alzheimer's disease mouse model. Curr Alzheimer Res. 2013; 10(8):829-43. DOI: 10.2174/15672050113109990135. View

Kim Y, Lee C . Glycyrrhizin Attenuates MPTP Neurotoxicity in Mouse and MPP-Induced Cell Death in PC12 Cells. Korean J Physiol Pharmacol. 2010; 12(2):65-71. PMC: 2817536. DOI: 10.4196/kjpp.2008.12.2.65. View

Stykel M, Ryan S . Nitrosative stress in Parkinson's disease. NPJ Parkinsons Dis. 2022; 8(1):104. PMC: 9372037. DOI: 10.1038/s41531-022-00370-3. View

Del-Bel E, Padovan-Neto F, Szawka R, da-Silva C, Raisman-Vozari R, Anselmo-Franci J . Counteraction by nitric oxide synthase inhibitor of neurochemical alterations of dopaminergic system in 6-OHDA-lesioned rats under L-DOPA treatment. Neurotox Res. 2013; 25(1):33-44. DOI: 10.1007/s12640-013-9406-3. View

Kurosaki R, Muramatsu Y, Michimata M, Matsubara M, Kato H, Imai Y . Role of nitric oxide synthase against MPTP neurotoxicity in mice. Neurol Res. 2002; 24(7):655-62. DOI: 10.1179/016164102101200717. View

Niranjan R . The role of inflammatory and oxidative stress mechanisms in the pathogenesis of Parkinson's disease: focus on astrocytes. Mol Neurobiol. 2013; 49(1):28-38. DOI: 10.1007/s12035-013-8483-x. View

Chen H, Zhao E, Zhang W, Lu Y, Liu R, Huang X . Meta-analyses on prevalence of selected Parkinson's nonmotor symptoms before and after diagnosis. Transl Neurodegener. 2015; 4(1):1. PMC: 4322463. DOI: 10.1186/2047-9158-4-1. View

10.

Dehay B, Bove J, Rodriguez-Muela N, Perier C, Recasens A, Boya P . Pathogenic lysosomal depletion in Parkinson's disease. J Neurosci. 2010; 30(37):12535-44. PMC: 6633458. DOI: 10.1523/JNEUROSCI.1920-10.2010. View

11.

Brooks S, Dunnett S . Tests to assess motor phenotype in mice: a user's guide. Nat Rev Neurosci. 2009; 10(7):519-29. DOI: 10.1038/nrn2652. View

12.

Aras S, Tanriover G, Aslan M, Yargicoglu P, Agar A . The role of nitric oxide on visual-evoked potentials in MPTP-induced Parkinsonism in mice. Neurochem Int. 2014; 72:48-57. DOI: 10.1016/j.neuint.2014.04.014. View

13.

Watanabe Y, Kato H, Araki T . Protective action of neuronal nitric oxide synthase inhibitor in the MPTP mouse model of Parkinson's disease. Metab Brain Dis. 2007; 23(1):51-69. DOI: 10.1007/s11011-007-9080-3. View

14.

Benavides G, Liang Q, Dodson M, Darley-Usmar V, Zhang J . Inhibition of autophagy and glycolysis by nitric oxide during hypoxia-reoxygenation impairs cellular bioenergetics and promotes cell death in primary neurons. Free Radic Biol Med. 2013; 65:1215-1228. PMC: 3859859. DOI: 10.1016/j.freeradbiomed.2013.09.006. View

15.

Tang Z, Li T, Chang L, Zhu H, Tong Y, Chen X . Glycyrrhetinic Acid triggers a protective autophagy by activation of extracellular regulated protein kinases in hepatocellular carcinoma cells. J Agric Food Chem. 2014; 62(49):11910-6. PMC: 4264863. DOI: 10.1021/jf503968k. View

16.

Canini F, Brahimi S, Drouet J, Michel V, Alonso A, Buguet A . Metyrapone decreases locomotion acutely. Neurosci Lett. 2009; 457(1):41-4. DOI: 10.1016/j.neulet.2009.03.103. View

17.

Hirsch E, Jenner P, Przedborski S . Pathogenesis of Parkinson's disease. Mov Disord. 2012; 28(1):24-30. DOI: 10.1002/mds.25032. View

18.

Tiwari P, Chaudhary M, Pal R, Nath R . Effects of mangiferin and its combination with nNOS inhibitor 7-nitro-indazole (7-NI) in 6-hydroxydopamine (6-OHDA) lesioned Parkinson's disease rats. Fundam Clin Pharmacol. 2022; 36(6):944-955. DOI: 10.1111/fcp.12817. View

19.

Zhu J, Horbinski C, Guo F, Watkins S, Uchiyama Y, Chu C . Regulation of autophagy by extracellular signal-regulated protein kinases during 1-methyl-4-phenylpyridinium-induced cell death. Am J Pathol. 2007; 170(1):75-86. PMC: 1762689. DOI: 10.2353/ajpath.2007.060524. View